Waters’ Centers of Innovation Program Honors Ohio State University Laboratory
News Sep 23, 2015
At a ceremony at The Ohio State University, Waters Corporation has officially welcomed the University’s Campus Chemical Instrument Center into the Waters Centers of Innovation Program. Headed by Prof. Vicki Wysocki, an Ohio Eminent Scholar and Professor of Chemistry and Biochemistry, the Center is widely renowned for fundamental research into ways of characterizing protein complexes, or assemblies of multiple individual proteins, that living organisms depend on for their survival.
Ultimately, the research of the Wysocki Research Group could one day lead to new understanding of conditions, such as high blood pressure, arteriosclerosis, pre-eclampsia, and chronic obstructive pulmonary disease, among others.
“We are honored to join the Waters Centers of Innovation Program as a partner and applaud the state-of-the-art instrumentation and technical support that Waters has provided,” said Caroline Whitacre, Vice President for Research at Ohio State. “Having access to the Waters technology has enabled the stellar work of Dr. Wysocki as she works to develop improved mass spectrometry approaches to determine structures of protein complexes. This research is helping researchers across the Ohio State campus and elsewhere to achieve breakthroughs and develop solutions that will have global impact.”
Also on hand to congratulate Prof. Wysocki and her team was Eric Fotheringham, Director, Waters Centers of Innovation Program. “Vicki is an exemplary scientist and a highly-respected member of the worldwide mass spectrometry community. She is certainly deserving of this recognition and we are proud to have her participate in our program.”
Abetting Wysocki in her research are advances in mass spectrometry technologies that allow her to probe the structures of protein complexes like never before.
“One of the important goals of our research is understanding how we might interrupt a disease or correct for a disease, or develop a drug target. Waters instruments are important to our research because of the ion mobility technology embedded in their quadrupole time-of-flight mass spectrometers. This technology allows us to measure not just a protein complex’s mass/charge ratio but also their shape, and this is incredibly important if we are to understand their function or identify when unfolding has occurred, which can be a sign of damage caused by an adverse event,” said Wysocki.
The driving force behind the technique of surface induced dissociation (SID) for mass spectrometry, Prof. Wysocki leads a research group exploring new ways of examining protein complexes by experimenting with SID on various instrument platforms. A mother, a teacher and a mentor, Prof. Wysocki is also an officer with the American Society for Mass Spectrometry (ASMS), currently serving as Vice-President for Programs.
In 1992, Professor Wysocki received an ASMS Research Award, presented annually to young academic scientists to further her research in mass spectrometry, and in 2009 she received a Distinguished Contribution to Mass Spectrometry Award, the Society’s highest achievement award. She is also one of 120 distinguished scientists, and one of six women, profiled in Elsevier’s Encyclopedia of Mass Spectrometry (2015) for contributions to mass spectrometry over the last century.
In recognition of Prof. Wysocki, Waters is sponsoring a symposium on Tuesday, September 22 titled Mass Spectrometry in Structural Biology on the campus of The Ohio State University. Giving invited lectures at the Symposium are Prof. David Russell, Texas A&M Prof. Joseph Loo, UCLA; Prof. Evan Williams, UC Berkeley; Prof. Lisa Jones, IUPUI; Prof. Perdita Barran, University of Manchester (UK); Prof. David Clemmer, Indiana University; and Kevin Giles, Waters Corporation.
All in a Droplet: Atomic Resolution of ALS Protein ResolvedNews
Researchers have described atom-by-atom changes in a family of proteins linked to amyotrophic lateral sclerosis (ALS), a group of brain disorders known as frontotemporal dementia and degenerative diseases of muscle and bone.READ MORE